Proposed methodology for monitoring antiretroviral drugs price negotiations in Latin America and the Caribbean

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 26, Issue 2, 2009, Pages 137-147

  Osorio De Castro, Claudia G S ^a   Crisante, Maruja ^b   Miranda, Elaine S ^a   Oliveira, Egléubia A ^a   Oliveira, Maria A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b MINISTERIO DE SALUD   (Peru)

Author keywords

Anti HIV agents; Caribbean region; Drug costs; Latin America; National drug policy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE SPREAD; DISEASE TREATMENT; DRUG; HEALTH POLICY; HUMAN IMMUNODEFICIENCY VIRUS; NATIONAL STRATEGY; PHARMACEUTICAL INDUSTRY; PRICE DETERMINATION;

ATLANTIC ISLANDS; ATLANTIC OCEAN; BARBADOS; CARIBBEAN ISLANDS; CENTRAL AMERICA; HONDURAS; LESSER ANTILLES; PERU; SOUTH AMERICA;

ANTIRETROVIRUS AGENT;

ARTICLE; CENTRAL AMERICA; COMMERCIAL PHENOMENA; ECONOMICS; METHODOLOGY; SOUTH AND CENTRAL AMERICA; STATISTICAL MODEL;

ANTI-RETROVIRAL AGENTS; CARIBBEAN REGION; COMMERCE; LATIN AMERICA; MODELS, ECONOMIC;

EID: 70350318015     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892009000800006     Document Type: Article

References (36)

1. Kallings LO. The first postmodern pandemic: 25 years of HIV/AIDS. J Intern Med. 2008; 263(3):218-243
2. United Nations. Declaration of Commitment on HIV/AIDS 2001. United Nations General Assembly Special Session on HIV/AIDS. New York: UN; 2001 [cited 2008 May 10]. Available from: http://data.unaids.org/publications/irc-pub03/ aidsdeclaration-en.pdf.
3. Ford N, Wilson D, Costa Chaves C, Lotrowska M, Kijtiwatchakul K. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand. AIDS. 2007;21 Suppl 4:S21-9.
4. Chirac P, Von Schoen-Angerer T, Kasper T, Ford N. AIDS: patent rights versus patient's rights. Lancet. 2000;356(9228):502.
5. World Health Organization; Joint United Nations Program on HIV/AIDS. Accelerating Access Initiative. Widening access to care and support for people living with HIV/AIDS. Progress report 2002. Geneva: WHO/UNAIDS; 2002.
6. William J Clinton Foundation. 2006 Annual Report. New York: WJCF; 2007 [cited 2007 Oct 9]. Available from: http://www.clintonfoundation.org/about-the- clinton-foundation/ annual-financial-reports.
7. theglobalfund.org [Internet]. Geneva: GFATM; c2002-2009 [cited 2007 Oct 9]. Available from: http://www.theglobalfund.org/en/.
8. Seoane-Vazquez E, Rodriguez-Monguio R. Negotiating antiretroviral drug prices: the experience of the Andean countries. Health Policy Plan. 2007;22(2):63-72. Epub 2007 Feb 13.
9. Organização Pan-americana da Saúde; Organização Mundial da Saúde. 45° Conselho Diretor. 56a Sessão do Comitê Regional. Washington: PAHO/WHO; 2004 [cited 2008 Apr 5]. Available from: www.ops-oms.org/portuguese/gov/cd/cd45-10-p.pdf.
10. Bermudez J. UNITAID: innovative financing to scale-up access to medicines. In: Global Forum update on research for health: fostering innovation for global health. Vol.5. Woodbridge (UK): Pro-Brook Publishing; 2008. p. 184-185
11. Chaves GC, Oliveira MA. A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement. Bull World Health Organ. 2007;85(1):49-56.
12. Westerhaus M, Castro A. How do intellectual property law and international trade agreements affect access to antiretroviral therapy? PLoS Med. 2006;3(8):e332.
13. Fitzgerald J, Gomez, B. An open competition model for regional price negotiations yields lowest ARV prices in the Americas. Presentation to the 8th World STI/AIDS Congress, Punta del Este (Uruguay), December 2-5, 2003. Available from: www.paho.org/English/AD/FCH/AI/PriceNeg.pdf.
14. World Health Organization. Multi-country regional pooled procurement of medicines. Identifying key principles for enabling regional pooled procurement and a framework for inter-regional collaboration in the African, Caribbean and Pacific Island Countries. Geneva, Switzerland, 15-17 January 2007 [meeting report]. Geneva: WHO; 2007.
15. Organización Panamericana de la Salud; Ministerio de Salud y Ambiente de la Nación (AR). Países Latinoamericanos logran descuentos de hasta 55% en tratamiento para VIH/SIDA [press release]. Aug 5. Buenos Aires: OPS/MSAN; 2005.
16. Marin N, Osorio-de-Castro C. Información sobre negociación de precios ARV: Argentina, Paraguay, Uruguay. Informe técnico. Rio de Janeiro: OPS, NAF-ENSP/Fiocruz; 2005.
17. Seoane Vázquez E, Rodríguez-Monguió R. Análisis del impacto de la negociación de precios de medicamentos y reactivos para el VIH/ SIDA en los países Andinos. Informe técnico. Washington: Organización Pan Americana de la Salud; 2005.
18. Global AIDS Program. Monitoring and evaluation capacity building for program improvement. Field guide. Version 1. Atlanta: U.S. Centers for Disease Control and Prevention; 2003.
19. Chequer P, Cuchí P, Mazin R, García Calleja, JM. Access to antiretroviral treatment in Latin American countries and the Caribbean. AIDS. 2002;16 Suppl 3:S50-7.
20. Marin N, Luiza VL, Osorio-de-Castro CGS, Machado-dos-Santos S, organizadores. Assistência farmacêutica para gerentes municipais. Rio de Janeiro: OPAS/OMS; 2003.
21. Management Sciences for Health; Euro Health Group. Economics for drug management. In: Managing drug supply. The selection, procurement, distribution, and use of pharmaceuticals. Hartford (CT): Kumarian Press; 1997. p. 36.
22. Piola SF, Vianna SM. Economia da saúde: conceito e contribuição para a gestão da saúde. 3a ed. Brasília: IPEA; 1995. p. 5-21.
23. World Health Organization; Health Action International. Measuring medicine prices, availability, affordability and price components. 2nd ed. Geneva: WHO/HAI; 2003.
24. Galárraga O, O'Brien ME, Gutiérrez JP, Renaud-Théry F, Nguimfack BD, Beusenberg M, et al. Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS. 2007;21 Suppl 4:S97-103.
25. Chen HT. Theory driven evaluations. Newbury Park (CA): Sage Publications; 1990.
26. Hartz ZMA. Avaliação dos programas de saúde: perspectivas teórico metodológicas e políticas institucionais. Rev C S Col. 1999;4(2): 341-353
27. Dionisio D, Fabbri C, Messeri D. HIV drug policies and South markets: settling controversies. Therapy. 2008;5(5):707-717
28. Vasan A, Hoos D, Mukherjee JS, Farmer PE, Rosenfield AG, Perriëns JH. The pricing and procurement of antiretroviral drugs: an observational study of data from the Global Fund. Bull World Health Organ. 2006;84(5):393-398 Epub 2006 May 17.
29. World Health Organization. A model quality assurance system for procurement agencies. Recommendations for quality assurance systems focusing on pre-qualification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products. Geneva: WHO; 2007 [cited 2008 Apr 10]. (WHO/PSM/PAR/2007.3). Available from: www.who.int/medicines/publications/ ModelQualityAssurance.pdf.
30. Pan American Health Organization. Primera reunión del Grupo de Acompañamiento de las Negociaciones de Antiretrovirales (GAN/ ARV). Informe. Washington: PAHO; 2006 [cited 2008 Apr 18]. Available from: http:// www.paho.org/Spanish/AD/FCH/AI/ Informe-GAN-Dic-12-revisadonelly.pdf.
31. Kyomuhangi L. Prospects for financial sustainability of scaling up antiretroviral therapy programs. Health Pol Develop. 2005;3(2): 154-164
32. Boulet P, Garrison C, Hoen E. Drug patents under the spotlight: sharing practical knowledge about pharmaceutical patents. Geneva: Médecins sans Frontières; 2003.
33. Luiza VL, Osorio-de-Castro CGS, Nunes JM. Aquisição de medicamentos no setor público: o binômio qualidade-custo. Cad. Saúde Pública. 1999;15(4):769-776
34. Global Fund to Fight AIDS, Tuberculosis & Malaria [Internet]. Purchase price report. Geneva: GFATM; c2002-2009 [cited 2008 Dec 18]. Available from: http://web.theglobalfund.org/ReportServer/Pages/ReportViewer.aspx?/PRM/ Product+Price+Report
35. World Health Organization [Internet]. Global price reporting mechanism. Geneva: WHO; 2008 [cited 2008 Dec 18]. Available from: http://www.who.int/hiv/ amds/price/hdd/.
36. World Health Organization. Transaction prices for antiretroviral medicines and HIV diagnostics from 2004 to September 2008. Geneva: WHO; 2008.